[Form 4] Lifevantage Corporation Insider Trading Activity

Rhea-AI Filing Summary

Lifevantage Corp (LFVN) reporting person Kristen Cunningham, Chief Sales Officer, received equity awards on 08/26/2025. The filing shows a grant of 12,349 stock units (each convertible to one share) and 18,524 performance restricted stock units (PRSUs) representing target-level awards. Following the transactions, Cunningham beneficially owns 116,351 shares and 18,524 PRSU-equivalent shares reported as direct ownership. The stock units vest over time subject to continued service, and the PRSUs vest only if specified performance criteria are met, with potential payout up to 200% of target.

Positive

• 12,349 stock units awarded to the Chief Sales Officer, aligning compensation with stock ownership
• 18,524 PRSUs granted which tie pay to performance and may pay up to 200% of target, incentivizing achievement
• Clear multi-year vesting schedule disclosed, supporting retention through 2028

Negative

• PRSUs vest only if specified performance criteria are met, so actual issuance could be zero if targets are unmet
• Awarded units could dilute existing shareholders if and when converted into common stock
• Filing lacks the specific financial performance targets and measurement periods, limiting assessment of materiality

Insights

Compensation & Governance Analyst

TL;DR: Insider received time- and performance-based equity awards; routine for executive compensation.

The grant of 12,349 stock units plus 18,524 PRSUs aligns executive pay with shareholder outcomes by combining service-based vesting and performance conditions. Vesting schedules are multi-year and contingent on continued service; PRSUs further require achievement of defined financial metrics and may pay up to 200% at maximum performance. This is a standard mechanism to retain senior sales leadership and incentivize target achievement; no immediate cash transfer or exercise price is reported.

Securities Analyst

TL;DR: Transaction is disclosure of granted equity units, not a market sale or purchase.

The Form 4 records awards rather than open-market transactions. The reported $0 price and description indicate equity grants (stock units and PRSUs) rather than purchases. Investors should note these awards increase potential future share issuance if vested and earned, but the filing contains no information about timing of performance measurement periods or the precise financial targets, only vesting dates and payout multiplier at maximum performance.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cunningham Kristen

(Last) (First) (Middle)

3300 TRIUMPH BLVD, SUITE 700

(Street)

LEHI UT 84043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Sales Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	08/26/2025		A		12,349	A	$0	116,351	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Restricted Stock Units(2)	(3)	08/26/2025		A	V	18,524		(3)	(3)	Common Stock	18,524	$0	18,524	D

Explanation of Responses:

1. This reflects a stock unit award, in which each stock unit represents a right to receive one share of issuer common stock, which award will vest, subject to the reporting person's continued service with the issuer, as follows: (i) 5/12 of the total number of units will vest on September 10, 2026 and (ii) the remaining units will vest in equal installments as of the 10th day of the third month of each of the seven calendar quarters thereafter.

2. Each Performance Restricted Stock Unit ("PRSU") represents a right to receive one share of issuer common stock, with the total number of units reflecting the number that are eligible to be earned at target-level performance achievement. Upon achievement of the maximum level of the applicable performance criteria, the reporting person may become eligible to earn 200% of the target number of units.

3. The PRSUs will vest only to the extent the specified financial performance criteria are achieved and subject to the reporting person's continued service with the issuer, as follows: (i) 34% of the earned award will vest on September 10, 2026 (ii) 33% of the earned award will vest on September 10, 2027 and (iii) 33% of the earned award will vest on September 10, 2028.

Remarks:

	/s/ Alissa Neufeld, Power of Attorney for Kristen Cunningham	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Kristen Cunningham receive in the Form 4 for LFVN?

The filing shows a grant of 12,349 stock units and 18,524 performance restricted stock units (PRSUs) dated 08/26/2025.

Do the PRSUs granted to the LFVN executive have performance conditions?

Yes. The PRSUs vest only to the extent specified financial performance criteria are achieved, and may pay up to 200% of target at maximum performance.

When do the awarded stock units and PRSUs vest according to the filing?

Stock units vest beginning September 10, 2026 (5/12 of units) with remaining units vesting in equal installments on the 10th day of the third month of each of the next seven calendar quarters; PRSUs vest in portions on September 10, 2026, 2027, and 2028 subject to performance and continued service.

How many shares does Kristen Cunningham beneficially own after the reported transaction?

Following the reported transactions, the filing reports 116,351 shares beneficially owned and 18,524 PRSU-equivalent shares reported as direct ownership.

Was there any cash paid for these awards according to the Form 4?

No. The reported price for both stock units and PRSUs is listed as $0, indicating equity grants rather than purchases.